IPC Looks to Technology Experts to Accelerate Digital Transformation and AI Adoption

What happened:

The Indian Pharmacopoeia Commission (IPC) has called for experienced technology professionals to participate in its next step of digital transformation. The draft IT expert committee will provide recommendations to the organization on topics like digital infrastructure, modernization of laboratory infrastructure, Artificial Intelligence, cyber security, data management, etc.

The transfer takes place with the goal of enhancing IPC’s technical capacity in the country to continue strengthening pharmaceutical quality systems and regulatory activities.

Why it matters:

Digital technology is becoming more and more used in the pharmaceutical industry, particularly for quality testing, regulatory compliance and decision making. Institutions responsible for drug quality standards are being put under increasing pressure to deal with the flood of scientific data in an accurate, transparent and compliant manner.

IPC is seeking to recruit experts from other industries, such as AI, laboratory automation, cybersecurity, networking and data analytics to enhance its systems and make them more efficient. The project is also contributing to a broader push to use technology to expedite the regulatory process and improve public health systems.

Industry context:

Regulatory bodies worldwide are devoting time to digital technologies. It is to improve efficiencies and eliminate manual processes. In order to improve traceability, increase workflow efficiency and maintain data integrity, labs are getting more and more engaged with automation. 

The drive aligns with India’s overall effort to move towards digital government and evolving the use of AI in public government bodies. It also highlights the need for a new “combinative” understanding which goes beyond science for today’s regulatory systems.  A strong digital infrastructure, data security and intelligent automation are also helping to drive effective healthcare regulation.

Investing in digital capabilities will greatly benefit the expanding Indian pharmaceutical sector by allowing regulatory bodies to efficiently manage the complexity that has increased with the sector, while upholding high quality, safety and compliance standards